We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
301
Quantbot Technologies
New York
– -$761K -8,260 Closed
DM
302
Deerfield Management
New York
– -$643K -6,978 Closed
Two Sigma Investments
303
Two Sigma Investments
New York
– -$581K -6,300 Closed
DFCM
304
Dark Forest Capital Management
Puerto Rico
– -$515K -5,584 Closed
SSG
305
Summit Securities Group
New York
– -$461K -5,000 Closed
DS
306
DRW Securities
Illinois
– -$332K -3,600 Closed
APWM
307
Argonautica Private Wealth Management
Massachusetts
– -$250K -2,714 Closed
CIM
308
Contravisory Investment Management
Massachusetts
– -$249K -2,706 Closed
Wealth Enhancement Advisory Services
309
Wealth Enhancement Advisory Services
Minnesota
– -$242K -2,622 Closed
CGH
310
Crossmark Global Holdings
Texas
– -$223K -2,427 Closed
AI
311
Atom Investors
Texas
– -$204K -2,214 Closed
KBC Group
312
KBC Group
Belgium
– -$40K -436 Closed
Macquarie Group
313
Macquarie Group
Australia
– -$18 -196 Closed
MSG
314
Main Street Group
Virginia
– -$17.2K -187 Closed
PAS
315
Point72 Asia (Singapore)
Singapore
– -$9.73K -106 Closed
HT
316
Headlands Technologies
Illinois
– -$5.25K -57 Closed
TSMHT
317
Thurston Springer Miller Herd & Titak
Indiana
– -$3.41K -37 Closed
Northwestern Mutual Wealth Management
318
Northwestern Mutual Wealth Management
Wisconsin
– -$2.77K -30 Closed
FGAM
319
Financial Gravity Asset Management
Texas
– -$213 -2 Closed
AW
320
Avion Wealth
Texas
– +$464 +5 New
9 10 11 12
13

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.